D.R. Horton Authorizes Massive $5 Billion Share Buyback Program

Key Facts

1D.R. Horton announced a new $5.0 billion stock buyback authorization with no expiration date.

2The company projects total fiscal 2026 repurchases to be at least $3.25 billion.

3Thermo Fisher Scientific became a minority owner and founding partner in Mayo Clinic's new Precure venture.

D.R. Horton announced a new $5.0 billion stock buyback authorization with no expiration date. The company stated it projects total fiscal 2026 repurchases to reach at least $3.25 billion, following the exhaustion of its prior plan which had approximately $53 million remaining.

DHI closed at $141.51 on September 25, 2026, marking a 0.83% increase from the previous session. Separately, Thermo Fisher Scientific became a minority owner in Mayo Clinic's new Precure venture; TMO closed at $675 on September 25, 2026.